KDR and telomere syndrome: While, as abovementioned, angiosarcoma, synovial sarcoma, liposarcoma, and undifferentiated polymorphic sarcoma have been reported to strongly express VEGFR2, and are expected to be excellent targets for TACTICs therapy, not all STS cases are VEGFR2 positive [13,14].